CLINICAL_TRIALS
trial_result
· 2020-05-22
Clinical Trial Update: A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression [Phase 2]
Summary
Phase 2 clinical trial of PX-866 in patients with glioblastoma at first relapse or progression has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NCIC Clinical Trials Group | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED | Results posted: 2020-05-22